Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: <i>Radiology</i> In Training.

Alabousi, Mostafa; Davenport, Matthew S

Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training.

Alabousi, Mostafa; Davenport, Matthew S.

Affiliation

Alabousi M; From the Department of Radiology, McMaster University, 1280 Main St W, Hamilton, ON, Canada L8S 4L8 (M.A.); and Departments of Radiology and Urology, Michigan Medicine, Ann Arbor, Mich (M.S.D.).
Davenport MS; From the Department of Radiology, McMaster University, 1280 Main St W, Hamilton, ON, Canada L8S 4L8 (M.A.); and Departments of Radiology and Urology, Michigan Medicine, Ann Arbor, Mich (M.S.D.).

Radiology ; 300(2): 279-284, 2021 08.

Article in En | MEDLINE | ID: mdl-34060939

Subject(s)

Contrast Media/adverse effects; Gadolinium DTPA/adverse effects; Kidney Failure, Chronic/complications; Nephrogenic Fibrosing Dermopathy/chemically induced; Administration, Intravenous; Aged; Contrast Media/administration & dosage; Gadolinium DTPA/administration & dosage; Humans; Kidney Failure, Chronic/therapy; Male; Renal Dialysis; Risk Factors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Contrast Media / Gadolinium DTPA / Nephrogenic Fibrosing Dermopathy / Kidney Failure, Chronic Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Radiology Year: 2021 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google